TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

25.30$ +1.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BEAM
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
84.8% 88.8% 60.6% 68.3% 86.3% 81.5% 83.0% 79.6% 85.7%
79.1% 87.7% 23.8% 35.9% 38.0% 17.3% 29.9% 25.5% 19.9%
79.1% 87.7% 58.8% 66.3% 65.5% 80.4% 81.5% 77.1% 84.1%
0.0% 20.3% 0.0%
-41.2%
10.1% 27.7% 27.8% 12.7% 17.5%
274.1% 19.7% 35.3% 45.6% 43.9% 45.3% 32.8% 33.5% 16.4%
273.3% 15.3% 18.7% 22.7% 14.5% 16.7% 14.1% 16.5% 6.5%
42.0% 3.6% 1.4% 0.7% 0.8% 0.9% 1.2% 1.0%
30.2% 4.4% 5.0% 1.4% 0.5% 0.7% 0.1% 0.4% 0.7%
2.8% 1.2% 0.2%
-174.1% 80.3% 64.7% 54.4% 56.1% 54.7% 67.2% 66.5% 83.6%
-393.9% -74.7% -130.1% -88.0% -52.1% -78.8% -81.5% -141.9% -110.8%
539.3% 21.0% 32.9% 10.3% 4.4% 5.2% 5.3% 7.5% 6.7%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?